PublicationsDiatech Admin2018-12-12T10:54:12+01:00

Publications

Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.

611, 2017

Elena Ongaro et al., A24Mutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer patients: the ROAD study

1810, 2017

Esther Diana Rossi et al.,Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group

1010, 2017

Elisabetta Tozzi et. al, The Headaches and Polymorphisms of the Methylenetetrahydrofolate Reductase

1809, 2017

Graziella Pinotti et al.,1335PEGFR T790M detection in TKI-naïve NSCLCs carrying sensitive EGFR mutations

1809, 2017

Elena Ongaro et al., 552PMutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer (aCRC) patients (pts): The ROAD study

809, 2017

Rossella Bruno et al., Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report. Oncology Letters

2508, 2017

Deans ZC et al., Review of the implementation of plasma ctDNA testing on behalf of IQN Path ASBL: a perspective from an EQA providers’ survey.

2408, 2017

Annamaria Ruzzo et al., Dihydropyrimidine dehydrogenase pharmaco- genetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients. British Journal of Cancer

1008, 2017

Gianni Bussolati et al., Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples. Plos One

1907, 2017

Marco Lucarelli et al., A New Targeted CFTR Mutation Panel Based on Next-Generation Sequencing Technology. The Journal of Molecular Diagnostics

1907, 2017

Francesca Galuppini et al., BRAF p.V600E-specific immunohistochemical assessment in colorectal cancer endoscopy biopsies is consistent with the mutational profiling. Histopathology

1807, 2017

Federico Pessina et al., Outcome evaluation of patients with newly diagnosed anaplastic gliomas treated in a single institution. Future Medicine

Previous 242526 Next